StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a report released on Wednesday morning. A number of other analysts have also recently commented on the stock. Royal Bank of Canada increased their price target on shares of Elevance Health from $574.00 to $575.00 and […]